1. Home
  2. EME vs NTRA Comparison

EME vs NTRA Comparison

Compare EME & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EMCOR Group Inc.

EME

EMCOR Group Inc.

HOLD

Current Price

$741.72

Market Cap

32.2B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.17

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EME
NTRA
Founded
1987
2003
Country
United States
United States
Employees
25000
N/A
Industry
Engineering & Construction
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2B
28.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
EME
NTRA
Price
$741.72
$197.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$831.67
$259.07
AVG Volume (30 Days)
338.5K
1.1M
Earning Date
06-01-2026
05-19-2026
Dividend Yield
0.22%
N/A
EPS Growth
30.99
0.65
EPS
28.19
N/A
Revenue
$16,986,422,000.00
$210,939,000.00
Revenue This Year
$7.48
$16.65
Revenue Next Year
$7.51
$19.22
P/E Ratio
$25.82
N/A
Revenue Growth
16.62
N/A
52 Week Low
$320.89
$125.38
52 Week High
$835.00
$256.36

Technical Indicators

Market Signals
Indicator
EME
NTRA
Relative Strength Index (RSI) 52.11 42.97
Support Level $600.37 $194.03
Resistance Level $747.78 $251.09
Average True Range (ATR) 21.46 8.27
MACD -2.51 0.24
Stochastic Oscillator 83.49 41.23

Price Performance

Historical Comparison
EME
NTRA

About EME EMCOR Group Inc.

EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: